C3i is attending the 10th Canadian Cancer Immunotherapy Consortium this week!

C3i will attend the 10th Canadian Cancer Immunotherapy Consortium in Montreal from December 13th to 15th to engage with researchers, clinicians and industry leaders in the Cancer Immunotherapy field. Danielle de Verteuil, for the Biomarker & Diagnostics unit, and Arnaud Deladeriere for the cGMP Manufacturing unit, will be representing and promoting C3i for its outstanding capacity to help biotech companies and pharmas to achieve their objectives. 

Get in touch to know more about C3i.


Danielle de Verteuil


Arnaud Deladeriere